ABOUT THIS EPISODE
Part 1 has landed!
Join in on their conversation on the Cell and Gene Therapy industry.
Some topics that Darwin and Rajiv discuss in this episode are:
- The current status of cell and gene therapy approvals,
- CMC challenges
- AAV-based gene therapy
Stay tuned to part 2 of their conversation. Remember to subscribe to the podcast to get the latest releases
Rajiv Gangurde LinkedIn profile: https://www.linkedin.com/in/rajiv-gangurde-ph-d-5b8ab5a/
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of SSI Executive Conversations.
OTHER EPISODES IN THIS PODCAST
First episode of 2025 proves to be a great one with Zack Lyon. Listen in.
Our next guest on the SSI Executive Conversation Podcast is Jennifer Fried, CEO and Co-founder of Flow Medical, a surgical software platform for treating pulmonary embolisms.
Some topics that Darwin and Jennifer discuss are:
- How Flow Medical started
- Why the technology is so significant
- Challe…
Just released, Part 2 of Darwin and Rajiv's discussion on Cell and Gene Therapy.
Some topics they discuss are:
- Clinical holds
- Gene Therapy developers and outsourcing
- Evolving regulatory guidance for C>.
Rajiv Gangurde LinkedIn: https://www.linkedin.com/in/rajiv-gangurde-ph-d-5b8ab5a/
#bi…
Part 3 is Here! Join Darwin and Aaron Snyder, VP of Quality at Allotex, as they wrap up with a powerful discussion on career growth, the critical role of career ladders, and how they drive higher retention, stability, and reduced risk in organizations.
Aaron Snyder LinkedIn: https://www.linkedin.…
Disclaimer: The podcast and artwork embedded on this page are from Darwin Shurig, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
